acetylcysteine has been researched along with sotorasib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahal, UP; David, B; Davies, R; Humphreys, WG; Ishida, K; Jiang, M; Lipford, JR; Monticello, TM; Siska, W; Stauber, J; Thomas, B; Wahlstrom, J; Werner, JA | 1 |
1 other study(ies) available for acetylcysteine and sotorasib
| Article | Year |
|---|---|
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Dose-Response Relationship, Drug; Male; Piperazines; Proto-Oncogene Proteins p21(ras); Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |